Reuters: Small Business News: Watson launches generic of ViroPharma's antibiotic

Reuters: Small Business News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Watson launches generic of ViroPharma's antibiotic Apr 10th 2012, 12:44 Tue Apr 10, 2012 8:44am EDT (Reuters) - Generic drugmaker Watson Pharmaceuticals Inc (WPI.N) said U.S. health regulators approved its copycat version of ViroPharma Inc's (VPHM.O) antibiotic Vancocin. Separately, ViroPharma said the U.S. Food and Drug Administration declined its citizen petition, which was filed to prevent Watson from launching the generic version. Shares of ViroPharma were trading down 18 percent at $23.40 in premarket. Watson said it has started shipping the drug, which recorded sales of $332 million for the 12 months ended February 29, 2012. ViroPharma shares closed at $28.61 on Monday on the Nasdaq.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions